⚠️ JAN 12 – FEB 6 CYBERATTACK: ALL ORDERS REFUNDED • DO NOT PURCHASE UNTIL FURTHER NOTICE • CONTACT support@anubis.estate FOR REFUND STATUS
Compassionate usePeptide

Compound 61439

Formula Pending

Molecular Mass
N/A
CAS Registry
AUTO-061439
Risk Class
MODERATE
Last Audit
Feb 9, 2108

Research Abstract

Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.

Compound 61439 is a peptide asset inside peptide innovation track initiatives, optimized for cellular repair and tissue regeneration.

The dossier currently sits in compassionate use with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.

Supply records cite CAS AUTO-061439 with updates logged 2108-02-09.

Acquisition Protocol

Authorized research personnel may request deployment of this compound for laboratory analysis.

Primary Vectors

Cellular repairTissue regeneration

Nomenclature

CX-61439Peptide Program 61439

Reference Material

  1. [1] Anubis Compound Registry • CAS AUTO-061439
  2. [2] Operations Pulse • Peptide innovation track
  3. [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61439